Market Signal Briefing

In its upcoming report, Alcon (ALC - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.77 per share, reflecting a decline of 4.9% compared to the same period last year. Revenues are forecasted to be $2.59 billion, representing a year-over-year increase of 6.5%.

Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

Given this perspective, it's time to examine the average forecasts of specific Alcon metrics that are routinely monitored and predicted by Wall Street analysts.

According to the collective judgment of analysts, 'Net Sales- Total Surgical' should come in at $1.42 billion. The estimate indicates a change of +6.1% from the prior-year quarter.

The consensus among analysts is that 'Net Sales- Total Vision care' will reach $1.17 billion. The estimate suggests a change of +7.1% year over year.

The collective assessment of analysts points to an estimated 'Net Sales- Total Surgical- Consumables' of $743.89 million. The estimate points to a change of +6.1% from the year-ago quarter.

The consensus estimate for 'Net Sales- Total Surgical- Equipment/other' stands at $245.51 million. The estimate suggests a change of +14.2% year over year.

The combined assessment of analysts suggests that 'Net Sales- Total Vision Care- Contact lenses' will likely reach $724.58 million. The estimate indicates a year-over-year change of +9.1%.

Analysts expect 'Net Sales- Total Vision Care- Ocular health' to come in at $448.60 million. The estimate indicates a change of +4.1% from the prior-year quarter.

It is projected by analysts that the 'Net Sales- Total Surgical- Implantables' will reach $430.00 million. The estimate points to a change of +1.9% from the year-ago quarter.

Based on the collective assessment of analysts, 'Revenues- Other revenues' should arrive at $19.52 million. The estimate suggests a change of -7.1% year over year.

Analysts forecast 'Net sales by region- United States' to reach $1.16 billion. The estimate suggests a change of +4.6% year over year.

Analysts predict that the 'Net sales by region- International' will reach $1.43 billion. The estimate points to a change of +8.2% from the year-ago quarter.

View all Key Company Metrics for Alcon here>>>

Alcon shares have witnessed a change of -2.9% in the past month, in contrast to the Zacks S&P 500 composite's +1.3% move. With a Zacks Rank #2 (Buy), ALC is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Golden Entertainment (GDEN - Free Report) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -125.00%. A quarter ago, it was expected that this gaming services provider would post earnings of $0.14 per share when it actually produced earnings of $0.17, delivering a surprise of +21.43%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

Golden Entertainment, which belongs to the Zacks Gaming industry, posted revenues of $154.82 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.98%. This compares to year-ago revenues of $161.23 million. The company has not been able to beat consensus revenue estimates over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Golden Entertainment shares have lost about 32.8% since the beginning of the year versus the S&P 500's gain of 15.6%.

What's Next for Golden Entertainment?While Golden Entertainment has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Golden Entertainment was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.13 on $167.48 million in revenues for the coming quarter and $0.31 on $648.32 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Gaming is currently in the top 33% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

GameSquare Holdings, Inc. (GAME - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025.

This company is expected to post quarterly loss of $0.03 per share in its upcoming report, which represents a year-over-year change of +78.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

GameSquare Holdings, Inc.'s revenues are expected to be $26.8 million, up 1.5% from the year-ago quarter.

A strong stock as of late has been Cardinal Health (CAH - Free Report) . Shares have been marching higher, with the stock up 24.7% over the past month. The stock hit a new 52-week high of $200.14 in the previous session. Cardinal has gained 66.4% since the start of the year compared to the 1.3% gain for the Zacks Medical sector and the 9.1% return for the Zacks Medical - Dental Supplies industry.

What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on October 30, 2025, Cardinal reported EPS of $2.55 versus consensus estimate of $2.21 while it beat the consensus revenue estimate by 8.39%.

For the current fiscal year, Cardinal is expected to post earnings of $9.73 per share on $254.73 in revenues. This represents a 18.08% change in EPS on a 14.44% change in revenues. For the next fiscal year, the company is expected to earn $10.85 per share on $274.61 in revenues. This represents a year-over-year change of 11.46% and 7.8%, respectively.

Valuation MetricsThough Cardinal has recently hit a 52-week high, what is next for Cardinal? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.

On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). The individual style scores for Value, Growth, Momentum and the combined VGM Score run from A through F. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.

Cardinal has a Value Score of A. The stock's Growth and Momentum Scores are A and B, respectively, giving the company a VGM Score of A.

In terms of its value breakdown, the stock currently trades at 20.2X current fiscal year EPS estimates, which is a premium to the peer industry average of 14.8X. On a trailing cash flow basis, the stock currently trades at 16.9X versus its peer group's average of 11.3X. Additionally, the stock has a PEG ratio of 1.53. This is good enough to put the company in the top echelon of all stocks we cover from a value perspective, making Cardinal an interesting choice for value investors.

Zacks RankWe also need to consider the stock's Zacks Rank, as this is even more important than the company's VGM Score. Fortunately, Cardinal currently has a Zacks Rank of #2 (Buy) thanks to a solid earnings estimate revision trend.

Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cardinal fits the bill. Thus, it seems as though Cardinal shares could still be poised for more gains ahead.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in APLD over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

SummaryThe Consumer Discretionary Select Sector SPDR Fund ETF (XLY) earns a Hold rating due to high concentration in Amazon and Tesla, limiting diversification.XLY's top two holdings, AMZN and TSLA, account for ~46% of the portfolio, amplifying idiosyncratic risk and reducing thematic purity.Valuation concerns, macro headwinds, and skepticism on TSLA's growth prospects further cap XLY's risk-adjusted return potential.Alternative ETFs like VCR and FDIS offer marginally better diversification, while RSPD's equal weighting addresses concentration risk more effectively. Khanchit Khirisutchalual/iStock via Getty Images

This thesis on The Consumer Discretionary Select Sector SPDR Fund ETF (XLY) critically evaluates the ETF on two aspects. One, whether XLY is the ETF I would prefer in the consumer discretionary space and

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

D-Wave Quantum (NASDAQ: QBTS) delivered a revenue beat this morning that sent shares up as much as 9.4% in early trading, though the stock pulled back 3.45% loss by mid-morning.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Shares of coffee retail chain Dutch Bros NYSE: BROS climbed 4% in after-hours trading on Wednesday following the company's blowout Q3 earnings call.

Key Takeaways Recursion Pharmaceuticals reported a Q3 loss of $0.36 per share, narrower than expected.Q3 revenues fell sharply to $5.2 million, missing estimates due to year-ago quarter Roche milestone timing.RXRX is advancing REC-4881, REC-1245, and other early-stage assets with data expected through 2027.
Recursion Pharmaceuticals (RXRX - Free Report) reported a loss of 36 cents per share in the third quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 38 cents. The company had incurred a loss of 34 cents per share in the year-ago quarter.

In the absence of an approved product, Recursion Pharmaceuticals only recognizes collaboration and grant revenues from its partners. Total revenues in the reported quarter amounted to $5.2 million, down significantly year over year, primarily due to the achievement of a $30 million milestone payment for the first phenomap from Roche, which was partially recognized in the year-ago quarter. The reported figure fell short of the Zacks Consensus Estimate of $17 million.

RXRX also recognizes periodic revenues from its ongoing collaboration agreements with Sanofi, Bayer and Merck KGaA, Darmstadt, Germany.

RXRX’s Q3 Results in DetailIn the third quarter of 2025, Research and development (R&D) expenses soared 62% to $121.1 million compared with the $74.6 million reported in the year-ago period. The massive uptick in R&D expenses can be attributed to an increase in acquired in-process R&D purchases related to the acquisition of full rights to REC-102, as well as its business combination with Exscientia in November 2024.

General and administrative (G&A) expenses were $41.6 million in the reported quarter, up 10% year over year, due to the inclusion of G&A expenses from the business combination with Exscientia. Additionally, Recursion Pharmaceuticals’ cost of revenues in the reported quarter increased 22% to $14.7 million.

The company had cash, cash equivalents and restricted cash worth $667.1 million as of Sept. 30, 2025, compared with $533.8 million as of June 30, 2025. Recursion Pharmaceuticals expects its existing cash, cash equivalents and restricted cash to fuel operations through the end of 2027, based on its current business plan.

RXRX shares have plunged 26.7% year to date against the industry’s 10.2% growth.

Image Source: Zacks Investment Research

RXRX’s Key Pipeline UpdatesIn the latest earnings release, Recursion Pharmaceuticals announced that it has earned a second $30 million milestone from its collaboration with Roche after the latter accepted a novel phenomap of microglial cells. RXRX expects to recognize a portion of this payment as revenues in the fourth quarter of 2025.

Recursion Pharmaceuticals faced a significant setback in May 2025 after announcing the discontinuation of three key drug candidates — REC-994, REC-2282, and REC-3964 — as part of its broader strategic pipeline reprioritization. These candidates were being developed for cerebral cavernous malformation, neurofibromatosis type II and Clostridioides difficile infection, respectively.

Following the terminations, Recursion Pharmaceuticals shifted focus to more promising candidates, notably REC-4881, which is being evaluated in a phase Ib/II TUPELO study for familial adenomatous polyposis. In May 2025, the company reported preliminary data from this study, with additional data expected in December 2025.

In 2024, Recursion Pharmaceuticals initiated its phase I/II DAHLIA study of REC-1245, a new chemical entity for the treatment of biomarker-enriched solid tumors and lymphoma. Data readout from the phase I portion of the DAHLIA study is expected in the first half of 2026. Recursion Pharmaceuticals is also developing a few other candidates, like REC-617 (advanced solid tumors) and REC-3565 (B-cell malignancies), in separate early-stage studies, anticipating data readouts in late 2025 and early 2027, respectively.

In July 2025, Recursion Pharmaceuticals acquired Rallybio’s full stake in their joint venture for developing REV102 (now REC102) and an associated backup molecule for the treatment of hypophosphatasia. REC102, a potent and selective ENPP1 inhibitor with strong preclinical safety data, is expected to enter phase I studies by late 2026. Its oral formulation offers a major advantage over current enzyme replacement therapies, potentially improving patient adherence and reducing treatment-associated risks.

RXRX’s Zacks Rank & Stocks to ConsiderRecursion Pharmaceuticals currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the biotech sector are ANI Pharmaceuticals (ANIP - Free Report) , Acadia Pharmaceuticals (ACAD - Free Report) and Amicus Therapeutics (FOLD - Free Report) . While FOLD currently sports a Zacks Rank #1 (Strong Buy), ANIP and ACAD carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

In the past 60 days, estimates for Amicus Therapeutics’ earnings per share have remained constant at 31 cents for 2025. During the same time, earnings per share estimates for 2026 have increased from 69 cents to 70 cents. Year to date, shares of FOLD have lost 4.5%.

Amicus Therapeutics’ earnings beat estimates in one of the trailing four quarters, missing the mark thrice, with the average negative surprise being 20.21%.

In the past 60 days, estimates for ANI Pharmaceuticals’ earnings per share have increased from $7.25 to $7.29 for 2025. During the same time, earnings per share estimates for 2026 have increased from $7.74 to $7.81. Year to date, shares of ANIP have surged 67.6%.

ANI Pharmaceuticals' earnings beat estimates in each of the trailing four quarters, the average surprise being 22.66%.

In the past 60 days, estimates for Acadia Pharmaceuticals’ earnings per share have increased from 52 cents to 53 cents for 2025. During the same time, earnings per share estimates for 2026 have increased from 78 cents to 84 cents. Year to date, shares of ACAD have surged 21.7%.

Acadia Pharmaceuticals’ earnings beat estimates in three of the trailing four quarters while missing the same on the remaining occasion, the average surprise being 16.90%.

Standard Chartered says Bitcoin’s strength determines DeFi’s ability to rival TradFi.Geoff Kendrick calls BTC the “apex asset” of decentralized finance.Bank outlines three-step Bitcoin accumulation plan below $100,000.Welcome to the US Crypto News Morning Briefing—your essential rundown of the most important developments in crypto for the day ahead.

Grab a coffee! Standard Chartered’s latest market note is not just about price targets. Geoff Kendrick, the bank’s Head of FX and Digital Assets Research, says Bitcoin now carries the weight of DeFi’s future. If it collapses, so could the dream of decentralized finance.

Sponsored

Crypto News of the Day: Standard Chartered Says Bitcoin Carries the Weight of DeFi’s FutureStandard Chartered’s Head of FX and Digital Assets Research, Geoff Kendrick, has warned that DeFi’s future hinges on one crucial condition: that Bitcoin remains structurally sound.

Speaking ahead of the Singapore FinTech Festival (SFF), Kendrick described Bitcoin as the “apex asset” underpinning DeFi’s growth. He also noted that any major collapse would undermine the broader digital finance movement.

“It is fair to say these days I spend most of my time talking about DeFi taking over TradFi…but for that to be possible, as the apex asset, Bitcoin needs to not collapse,” Kendrick wrote in an email.

His comments come as institutions, regulators, and innovators plan to converge in Singapore next week to discuss blockchain infrastructure and the future of open finance.

For Standard Chartered, one of the few major banks to actively publish digital asset research, Kendrick’s framing represents a shift from speculative to systemic thinking about Bitcoin’s role in the global economy.

Sponsored

While many analysts focus on price targets, Kendrick’s recent commentary emphasizes Bitcoin’s stability as a foundation for DeFi’s legitimacy.

“DeFi can’t replace traditional finance if its cornerstone asset is volatile or unreliable,” one market observer said in response to Kendrick’s remarks.

Against this backdrop, Kendrick laid out a structured three-step accumulation plan for Bitcoin investors, suggesting that the recent dip below $100,000 “may be the last one ever.” His proposed strategy includes:

Buying 25% of a target allocation at current levels,
Another 25% if Bitcoin closes above $103,000, and
The remainder (50%) once the Bitcoin–gold ratio climbs above 30.
It aligns with remarks from a previous note to clients, where Kendrick stated that Bitcoin’s sub-$100,000 moves could be its last. As indicated in a US Crypto News publication, the bank’s executive noted that it would also mark the final entry point before a renewed bull phase.

Sponsored

Charts of the Day50-week MA matters = Friday “close” of 103k above/below matters. Source: KendrickBitcoin-gold ratio matters = I would like it above 30. Source: Kendrick5-day MA of ETF inflows (USDmn) = outflows from both now. Source: KendrickSponsored

Byte-Sized AlphaHere’s a summary of more US crypto news to follow today:

Ethereum whales buy $1.37 billion in ETH amid 12% November price drop.
Bitwise CIO Matt Hougan: “Good DATs do hard things — bad DATs Get Punished.”
Circle bows to Second Amendment pressure in latest USDC policy update.
Robinhood Q3 crypto revenue surges to $268 million. Will they launch a token?
Metaplanet defies Bitcoin bear: Leveraging for long-term treasury.
Chainlink secures major deal with SBI Digital Markets amid LINK supply drop.
Zcash price breakout extends with volume support — No sign of exhaustion yet.
Why Internet Computer’s (ICP) 100% rally might just be getting started.
Crypto Equities Pre-Market OverviewCompanyAt the Close of November 5Pre-Market OverviewStrategy (MSTR)$255.00$252.70 (-0.90%)Coinbase (COIN)$319.30$318.90 (-0.13%)Galaxy Digital Holdings (GLXY)$31.44$32.17 (+2.32%)MARA Holdings (MARA)$17.33$17.09 (-0.23%)Riot Platforms (RIOT)$18.97$19.03 (+0.32%)Core Scientific (CORZ)$21.80$21.96 (+0.73%)Crypto equities market open race: Google FinanceDisclaimer

In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.

TL;DR

Robert Kiyosaki urged investors to prioritize Bitcoin and Ethereum as a way to preserve personal financial independence amid expanding government influence.
He linked recent political trends in the United States with a gradual erosion of free-market values and warned that traditional banking may no longer guarantee security.
He believes Bitcoin could climb toward 180,000 dollars by late 2025, supported by rising adoption and distrust in centralized systems.

Financial educator and author Robert Kiyosaki has renewed his message to global investors, encouraging them to safeguard their savings through Bitcoin and Ethereum. The Rich Dad Poor Dad author suggested that digital assets give individuals control over their money at a time of increasing state involvement in the economy. His comments on X reached millions and quickly sparked discussion across financial circles, especially among younger investors seeking alternatives to banks and bonds.

Kiyosaki referred to the recent New York mayoral election as a symbolic sign of shifting priorities in the United States. He argued that the outcome reflects a wider change that could reduce incentives for entrepreneurship and personal responsibility. According to him, this environment rewards dependency and increases the likelihood that governments attempt to influence financial decision-making. He encouraged individuals to strengthen their financial education and avoid relying solely on the traditional financial system.

Bitcoin And Ethereum As Tools For Personal Control
Kiyosaki has long supported gold, silver, and Bitcoin as ways to protect savings from inflation and debt-driven monetary policy. He now places Ethereum in the same category, highlighting its role in decentralized finance, tokenized assets, and smart contracts. He believes that both cryptocurrencies are more than investments. In his view, they represent a path toward personal control of wealth without interference from political agendas or central authorities.

He remains optimistic about future price performance. His current expectation suggests Bitcoin could approach 180,000 dollars before the end of 2025. He linked this projection to weakening confidence in the U.S. dollar, combined with an accelerating movement toward decentralized financial solutions and growing institutional demand for digital assets.

Shift Toward Decentralized Wealth Management
Kiyosaki maintains that relying on salaries, pensions, or traditional portfolios may no longer guarantee long-term prosperity. He promotes a model focused on independent learning, asset ownership, and exposure to decentralized technologies. He framed digital assets as part of a modern financial toolkit that enables individuals to build wealth beyond the reach of bureaucratic systems.

Although some analysts view his warnings as excessive, his influence among retail investors remains strong.  

Balancer has uncovered the technical root cause behind the recent hack that shook its platform.

Summary

Balancer identified a rounding bug in its “upscale” function as the cause of the exploit that drained assets across multiple networks.
Over $116 million was stolen, with losses spanning Ethereum, Arbitrum, Base, and Polygon, though StakeWise recovered $19 million of osETH for affected users.
Recovery efforts are ongoing, as the protocol and partners freeze vulnerable pools, trace stolen funds, and prepare a final report on asset reconciliation.

DeFi protocol Balancer has identified an internal bug in the rounding logic of the “upscale” function as the root cause of the November 3 exploit that drained over $116 million from its platform. According to a recently published preliminary report, the function, which is used during token swaps, was exploited by attackers across multiple networks, leading to swift losses of WETH, osETH, and wstETH that were pulled in several transactions.​​

Attackers took advantage of how the code handled non-integer scaling factors to manipulate pool balances and drain value. Balancer revealed the breach allowed hackers to move funds quietly within vaults before final withdrawal. 

In total, $116.6 million was stolen by the time the dust settled, with losses spanning several assets and networks, including Ethereum, Arbitrum, Base, and Polygon. Among the stolen tokens, the largest amounts included 6,587 WETH, 6,851 osETH, and 4,260 wstETH, as earlier reported and confirmed in the incident report.​

StakeWise, one of the affected protocols, managed to recover nearly $19 million worth of osETH, corresponding to about 73.5% of the total drained for that asset. These funds will be returned to impacted users according to their balances before the hack, though the attacker has also converted some assets into ETH, making them irretrievable.​

Balancer takes recovery actions 
Balancer and its security partners are still auditing the incident and reconciling the lost funds, with mitigation and recovery efforts ongoing. Following the exploit, security teams paused all affected pools, disabled the creation of new pools, and halted rewards for any pools identified as vulnerable, according to the project’s official incident report.

Several teams in the broader DeFi space also took steps to limit losses and contain attacker movements. Protocols like Sonic Labs executed an emergency freeze on accounts linked to the hack, while Berachain validators briefly halted their network to prevent funds from moving. Other partners, like Monerium and Gnosis, introduced controls to freeze or block assets as part of a coordinated stoppage.​

Whitehat teams and supporting bots intercepted transactions to claw back assets, with some managing to return hundreds of thousands of dollars. The efforts came from both automated systems and manual tracing, building a layered approach to asset recovery.​

Balancer noted that once all affected pools and transactions are verified, a final report will be published with confirmed totals and the status of recoveries. Until then, users are advised to avoid impacted contracts and follow updates via official channels, as further reviews and reconciliations are ongoing.​

Bitcoin.com and Concordium have teamed up to introduce age-verified stablecoin payments to 75 million wallets, blending privacy with new compliance standards.

The integration, powered by Chainlink’s NAVLink oracle technology, represents another leap in bridging traditional finance and decentralized finance together. Nov 6, 2025, 2:00 p.m.

Aave’s Horizon market, the DeFi protocol’s institutional-grade platform for real-world assets (RWAs), is getting a major boost as Securitize and VanEck bring their tokenized treasury fund, VBILL, to the platform.

STORY CONTINUES BELOW

The integration, powered by Chainlink’s NAVLink oracle technology, represents another leap forward in bridging traditional finance and decentralized finance (DeFi) together.

Since launching in August, Horizon has quickly grown into the fastest-expanding venue for RWAs in DeFi, surpassing $460 million in total market size, according to a press release shared with CoinDesk. The platform's aim is to meet institutional compliance standards while maintaining the transparency and liquidity of onchain finance.

VBILL, launched earlier this year by Securitize and VanEck, is the asset manager’s first tokenized fund.

Now, with VBILL added as eligible collateral, institutions can borrow stablecoins against their VBILL holdings. The integration into Aave Horizon is underpinned by Chainlink’s NAVLink and LlamaGuard NAV oracles, which provide verified, risk-adjusted net asset value (NAV) data to ensure tamper-resistant pricing, the team claims.

Securitize also plans to integrate its Trusted Single Source Oracle (TSSO) system in the future, adding another layer of verification for onchain fund valuation.

“Integrating VanEck’s VBILL with Aave and Chainlink expands access to one of the most trusted forms of onchain collateral and demonstrates how regulated assets can now move fluidly through DeFi,” said Carlos Domingo, the CEO of Securitize, in the press release.

Read more: Securitize, RedStone Pilot ‘Trusted Single Source Oracle’ to Secure Tokenized Fund NAVs

AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

Inside Zcash: Encrypted Money at Planetary Scale

Nov 3, 2025

A deep dive into Zcash's zero-knowledge architecture, shielded transaction growth, and its path to becoming encrypted Bitcoin at scale.

What to know:

In 2025, Zcash evolved from niche privacy tech into a functioning encrypted-money network:

Shielded adoption surged, with 20–25% of circulating ZEC now held in encrypted addresses and 30% of transactions involving the shielded pool.The Zashi wallet made shielded transfers the default, pushing privacy from optional to standard practice.Project Tachyon, led by Sean Bowe, aims to boost throughput to thousands of private transactions per second.Zcash surpassed Monero in market share, becoming the largest privacy-focused cryptocurrency by capitalization.View Full Report

More For You

Cango Eyes Strengthening of Bitcoin Mining Operations, Entry Into AI HPC Market

45 minutes ago

The Chinese automotive transaction firm turned bitcoin miner Cango issued an update to its shareholders.

What to know:

Cango said it will prioritize optimizing its bitcoin mining business by improving uptime and improving the energy efficiency of its operations.The company is also pursuing a targeted entry into AI HPC.Cango's board has approved a direct listing on the New York Stock Exchange, which it expects to go live on Nov. 17.Read full story

Journalist

Posted: November 6, 2025

Key Takeaways
What do Algorand’s TD Sequential and RSI suggest about its next move?
Both indicators point to potential bullish relief as ALGO holds key support near $0.152, with RSI rebounding from oversold territory.

How are traders positioning themselves for the possible breakout?
Long accounts dominate at nearly 58% on Binance, reflecting growing optimism that ALGO could reclaim $0.165 and target $0.20.

The TD Sequential indicator has printed two consecutive buy signals on Algorand’s [ALGO] daily chart, fueling optimism for a rebound after a steep decline. 

The Spot Taker CVD shows buy-side dominance, implying that buyers are regaining short-term control. 

Trading near $0.16 at press time, ALGO has defended the lower edge of its descending channel, showing that demand remains active at this level. 

Historically, similar dual confirmations have coincided with local bottoms, often preceding relief rallies. 

As buyer strength increases, momentum could build toward the $0.20 resistance zone, where broader validation of recovery might begin to unfold. 

Can Algorand reclaim strength?
Algorand continued to trade inside a falling channel that has defined its structure since July. Recently, the token rebounded from the lower boundary near $0.152, where buying demand has consistently emerged. 

The RSI sat near 35, reflecting oversold conditions that often precede short-term relief rallies. The technical landscape suggested that a close above $0.165 could confirm a shift in momentum toward $0.20. 

However, losing the $0.152 support would expose the token to another leg lower. Traders are closely watching this zone as the TD Sequential’s buy signal and RSI recovery converge around this crucial technical point.

Source: TradingView

Growing trader optimism
Binance data shows that 57.99% of traders were holding long positions at press time, compared to 42.01% short, pushing the long-to-short ratio to 1.38. 

This jump highlights renewed optimism and rising appetite for leveraged bullish exposure. The timing aligns with the TD Sequential buy setup, reinforcing that traders expect a rebound. 

However, as long positions build, the risk of volatility increases if prices face rejection at upper resistance zones. 

Still, the correlation between growing long positions and the RSI’s gradual uptick suggests improving sentiment that could amplify upward momentum should buying pressure sustain through the coming sessions.

THIS will decide Algorand’s next breakout
The liquidation map on Binance revealed dense clusters between $0.155 and $0.165, marking a key liquidity pocket where leveraged positions are concentrated. 

This zone acts as a pressure point that could trigger either a sharp breakout or a steep pullback, depending on direction. 

If Algorand breaks above $0.165, thin liquidity above could fuel a quick rise toward $0.20. Conversely, a drop below $0.155 might trigger cascading liquidations, dragging the price toward $0.145. 

Hence, this narrow corridor represents a battleground that will likely dictate Algorand’s short-term volatility and trend continuation prospects.

Can bullish signals translate into…?
Algorand’s outlook has improved with the TD Sequential double buy signal, rising long exposure, and RSI recovery, all hinting at potential reversal momentum. 

Maintaining support above $0.152 while clearing $0.165 would confirm this bullish setup and possibly open the door to $0.20. 

However, tight liquidation zones and rising leverage introduce risk if buying pressure weakens.

Sustained accumulation across both Spot and Futures markets will be critical for ALGO to transform this rebound signal into a broader recovery phase.

Is the AI bubble quietly building a fault line that could shake Bitcoin and crypto the way dot-com fever once did?

Summary

The AI bubble is inflating fast, with valuations soaring as speculation outpaces real profits, productivity, and measurable business performance.
Reports reveal heavy AI sector cross-investing and record losses, prompting fears of inflated metrics and government-backed corporate dependence.
Analysts and institutions compare today’s AI boom with the dot-com era, warning that over-financing could trigger a global correction.
Crypto mirrors market anxiety as Bitcoin falls sharply amid fears that an AI-led downturn could deepen risk across digital assets.

The AI bubble and its money loop
Artificial intelligence is fueling a modern gold rush across technology and finance. The boom has reshaped industries from chipmaking to software, sending company valuations to record levels.

Yet many economists and investors warn that excitement may have surpassed the underlying fundamentals. They describe the surge as an “AI bubble,” recalling the late 1990s dot-com era when innovation collided with speculation and markets eventually crashed.

The concern lies in how capital moves through the sector. AI firms are investing heavily in each other’s infrastructure, cloud services, and hardware, creating a circular flow of money that inflates valuations based more on future expectations than on actual profit.

Reports show that OpenAI, one of the central players in this wave, is seeking U.S. federal loan guarantees to support infrastructure projects. 

Chief Financial Officer Sarah Friar confirmed the effort at a Wall Street Journal event, explaining that such guarantees could lower borrowing costs given the vast scale of planned data centers and a $300 billion partnership with Oracle.

Once a nonprofit research lab, OpenAI now operates as a for-profit company that needs tens of billions in annual revenue just to cover computing and energy costs. 

Its model increasingly resembles capital-intensive sectors such as semiconductor manufacturing, where governments often intervene with subsidies or credit support to keep early growth stable.

Skeptics question whether the numbers truly add up. Julian Brigden, co-founder of Macro Intelligence 2 Partners, asked on X why a firm expected to earn “hundreds of billions of dollars” would still require taxpayer guarantees, calling it a possible warning sign of liquidity pressure.

Meanwhile, Michael Burry, the hedge-fund manager known for predicting the 2008 housing collapse, has made a large short bet against the AI sector. 

According to filings with the U.S. Securities and Exchange Commission, his firm Scion Asset Management purchased about $187.6 million in put options on Nvidia and $912 million on Palantir, signaling his view that leading AI firms could face sharp valuation declines.

The mood around these moves has spilled into other speculative markets. Crypto, which often mirrors technology stock behavior, has seen steep losses in recent weeks. 

The total market cap fell from around $4.2 trillion on Oct. 6 to $3.43 trillion a month later, an 18% decline. Bitcoin (BTC) alone dropped nearly 19% in the same period, from $126,000 to roughly $103,000 as of Nov. 6, marking one of its steepest monthly declines in years.

Bitcoin price chart | Source: crypto.news
Let’s understand what is developing beneath the surface, what warning signals are emerging, and how a potential correction in AI markets could spill over into crypto will be crucial in the weeks to come.

Circular cashflows, not real growth
The first real stress test of the AI boom came in early 2025. In January, DeepSeek, a Chinese-developed chatbot, gained unexpected global traction after outperforming its rivals across several benchmarks. 

The surprise sent markets reeling and triggered a sharp correction in leading AI stocks. Nvidia, which had been the centerpiece of the AI surge, fell 17% in a single trading session before recovering 8.8% the following day.

Concerns deepened as actual performance data started emerging later in the year. A Massachusetts Institute of Technology study found that despite $30 to $40 billion in enterprise spending on generative AI, 95% of companies reported no measurable return.

Crypto analyst Hedgie noted that OpenAI lost $13.5 billion on $4.3 billion in revenue during the first half of 2025, meaning ChatGPT continues to operate at a loss nearly every time it is used. 

🦔How catastrophic is it if the AI bubble bursts? Let me break this down.

OpenAI lost $13.5 billion on $4.3 billion in revenue for H1 2025. ChatGPT loses money almost every time you use it. Yet OpenAI targets a $1 trillion IPO based on storytelling, not business fundamentals. An…

— Hedgie (@HedgieMarkets) November 5, 2025

Yet the company is reportedly seeking a $1 trillion IPO, a valuation critics describe as driven more by hype than by business fundamentals.

Market analyst Hedgie described what he called “circular financing,” where companies like Nvidia invest heavily in AI startups that then spend most of that money buying Nvidia hardware. He likened it to giving a lemonade stand $10 to buy $10 worth of lemons and then counting it as $20 of economic growth.

In the first half of 2025, data center spending emerged as one of the largest contributors to U.S. GDP growth, surpassing consumer spending. That growth, however, came largely from corporate expenditure rather than actual revenue generation.

Meanwhile, spending forecasts vary widely, but analysts agree that AI infrastructure spending is set to surge through the decade. Citigroup estimates that major U.S. technology companies could collectively spend more than $2.8 trillion on AI infrastructure by 2029. 

Nvidia’s valuation becomes the clearest symbol of this exuberance. In July 2025, it had become the world’s most valuable company, reaching a $4 trillion market cap, four times its 2023 level. The company alone represented about 7.3% of the S&P 500 index, which also hit record highs during the same period.

Three months later, Nvidia’s valuation surpassed $5 trillion, a figure larger than the GDP of any country except the U.S. and China, based on World Bank data. 

Moreover, AI-related firms have been largely responsible for roughly 80% of all U.S. stock market gains throughout 2025, prompting analysts to question whether the rally stemmed more from concentrated financial exposure than from real productivity growth.

The debate around a potential AI bubble has grown unusually self-aware. Even Sam Altman, CEO of OpenAI and the public face of the current AI boom, admitted in 2025 that an investment bubble is forming.

His acknowledgment carried weight, as OpenAI’s valuation surged from $157 billion in late 2024 to about $500 billion within a year. The company’s rapid growth has come with record infrastructure spending and projections that depend more on sustained investor enthusiasm than on consistent profits.

Several prominent investors have drawn parallels between today’s AI market and earlier speculative eras. Ray Dalio, co-chief investment officer of Bridgewater Associates, said in early 2025 that the scale of AI investment looks “very similar” to what he witnessed during the dot-com boom. 

In October, JPMorgan CEO Jamie Dimon remarked that while AI is a genuine and transformative technology, a large portion of the capital pouring into it may eventually be lost. He warned that markets could be underestimating the chance of a major stock correction within the next two years. 

The Bank of England also cautioned that valuations of leading AI firms, including OpenAI, could prove unsustainable if infrastructure needs exceed what can be financed or managed efficiently. Its report said investors were not sufficiently warned about the risk of a sharp downturn if AI fails to deliver expected performance and profitability.

The International Monetary Fund echoed that concern. Managing director Kristalina Georgieva drew a clear link to the 2001 dot-com collapse, warning that a sudden AI market correction could slow global growth and hit developing economies hardest, especially those dependent on foreign investment and technology imports.

Goldman Sachs, however, offered a more optimistic interpretation. The firm argued that the surge in U.S. technology stocks might be supported by durable profit growth, noting that current valuations remain moderate compared with the late 1990s. 

Meanwhile, Federal Reserve Chair Jerome Powell recently mentioned that AI differs from earlier bubbles because many of the companies driving the current cycle already generate real revenue. He pointed to data center construction and related infrastructure spending as tangible sources of economic activity.

Bitcoin feels the ripple effects
Bitcoin remains under pressure as investor sentiment weakens and economic uncertainty rises. Data from CoinGlass shows the asset has already fallen nearly 11% this quarter, making it the second-worst Q4 since 2020. October alone saw a 3.85% decline, marking the weakest October performance since 2018.

Alex Thorn, Head of Firmwide Research at Galaxy, has lowered his year-end Bitcoin target from $185,000 to $120,000. In a note to clients, he said large holders are offloading coins, corporations are showing reduced interest in holding Bitcoin in their treasuries, and investors are diversifying into other assets.

i’m lowering my BTC bullish EOY target to $120k (prev $185k) 👀

just sent this note to clients

whale distribution, non-BTC investments, treasury company malaise, and other factors contributed to BTC headwinds in 25

(long-term future still bullish, of course) pic.twitter.com/2aj1eoJlno

— Alex Thorn (@intangiblecoins) November 5, 2025

Thorn remains optimistic about Bitcoin’s long-term outlook but expects short-term performance to stay weak due to tightening liquidity and a slowdown in institutional demand.

On-chain data supports that caution. Analyst Maartunn observed that long-term holders currently control about 73.6% of Bitcoin’s total supply, near record highs.

🧵 Bitcoin On-Chain: LTH vs STH — The Truth You Need to Know

Most watch price.
Smart money watches holders.

Here’s what the data says about Long-Term vs Short-Term Holders right now 👇 pic.twitter.com/9v8wgQJBkW

— Maartunn (@JA_Maartun) November 6, 2025

However, in the past month, roughly 363,000 Bitcoins have moved from long-term wallets into short-term hands, indicating active profit-taking as seasoned holders sell and newer investors absorb the coins.

Older wallets are also becoming active again. Over the past year, more than 1.17 million Bitcoins that had been untouched for three to five years have been spent, alongside several hundred thousand from even older addresses.

Maartunn noted that the market now stands at a crossroads. If short-term holders remain calm, prices could stabilize. If they begin selling aggressively, the next leg down could be steeper.

Combined with a global environment that is already under pressure from slowing growth, rising costs, and fears of an AI-driven market correction, crypto investors are facing multiple risks at once. Investors should remain careful, manage exposure sensibly, and never commit more than they can afford to lose.

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.

Fundstrat's Tom Lee has warned that tightening market liquidity and risk headwinds continue to weigh on Bitcoin (CRYPTO: BTC) and other cryptocurrencies.

Liquidity Headwinds Drag On BitcoinSpeaking on CNBC on Wednesday, Lee said Bitcoin remains “highly sensitive to liquidity conditions” and broader market risk sentiment. 

He pointed to a mix of macro headwinds — from the U.S. government shutdown to a hawkish Federal Reserve stance — as catalysts weighing on digital assets.

"The Treasury general account has been building cash," Lee explained. 

"That created a cascade of problems that put pressure on crypto." He added that liquidity stress is a leading factor for Bitcoin's volatility, noting that as funding pressures ease, "headwinds can turn into tailwinds."

Technical Breakdown Confirms Seller Control

BTC Technical Analysis (Source: TradingView)

Bitcoin lost its ascending trendline that supported the entire rally from May, breaking below multiple moving averages. 

The 20-, 50-, and 100-day EMAs now sit overhead between $108,700–$111,700, forming a strong resistance cluster.

The daily candle also shows a clean move into the $100,000–$98,000 demand zone, an area that previously triggered aggressive rebounds. 

If price fails to hold this level, the next major high-volume support sits between $94,000–$92,500, where prior accumulation occurred during the summer rally.

Lee Expects Deleveraging To Take WeeksLee compared the current drawdown to the major deleveraging episodes in 2020 and 2022, when the COVID shock and FTX collapse triggered widespread liquidations. 

He said the Oct.10 deleveraging event was "the biggest in history," and that ripple effects are still being felt.

"The good news is there aren't a lot of bodies floating to the surface," Lee noted. 

"It doesn't feel systematic, but it's going to take some time for confidence to come back." 

He expects the crypto market to stabilize gradually as selling pressure eases and confidence rebuilds over the coming weeks.

Equity Correlation And Investor SentimentLee also linked the weakness in digital assets to profit-taking in equities, particularly the Nasdaq 100, which has rallied for six consecutive months. 

He suggested that both crypto and high-growth stocks are experiencing short-term fatigue after extended gains.

Still, Lee remains constructive on longer-term prospects, citing historical data showing markets that rise six months in a row typically post another 3% average gain in the following month. 

"It's actually a good sign we've been up for six months straight," he said.

Read Next:

Supreme Court Could Blow Up Your 60/40 Portfolio By December — Here’s How To Hedge
Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

You're reading Crypto Long & Short, our weekly newsletter featuring insights, news and analysis for the professional investor. Sign up here to get it in your inbox every Wednesday.

TL;DR:

Trump’s “Bitcoin superpower” remarks fuel a 11.8% TRUMP coin surge.
Whale inflows and bullish charts signal possible targets near $20.
Expansion rumors with Republic.com boost long-term optimism.

The Official Trump coin has reignited market enthusiasm after US President Donald Trump declared his ambition to make the country a “Bitcoin superpower.” The politically charged memecoin surged as traders reacted to Trump’s renewed crypto-friendly stance and speculation over a potential expansion deal.

Trump’s Bitcoin vision fuels a market rally
The Official Trump coin soared 11.8% in 24 hours, trading near $7.88 and outperforming the broader market, which fell 1.3%. The rally followed Trump’s remarks positioning Bitcoin and digital assets as tools to “take pressure off the dollar” and enhance US competitiveness against China. Trading volume surpassed $1 billion on major exchanges, signaling heightened interest.

Technical indicators confirm bullish momentum. Prominent analysts noted that TRUMP’s price broke out of a long-term falling wedge pattern, a classic bullish setup. The coin cleared key resistance at $7.96 and bounced off its 50-day exponential moving average of $7.29. With the RSI around 57 and the MACD showing a positive crossover, market signals point to sustained upward potential, possibly reaching $18–$20 if momentum continues.

Whale accumulation strengthens the trend. On-chain data revealed $91 million in net inflows over three days, while open interest doubled to $351 million. Funding rates turned positive, suggesting long positions now dominate. Yet, analysts warn that centralization concerns remain, as roughly 80% of TRUMP’s supply is reportedly controlled by entities linked to Trump’s inner circle, creating potential volatility risks if profit-taking occurs.

Expansion rumors amplify investor speculation. Reports suggest that Fight Fight Fight LLC, the token’s issuer, is negotiating to acquire Republic.com’s US operations. If realized, the deal could integrate TRUMP into startup fundraising and payment systems, expanding its real-world use cases.

For now, Trump’s pro-Bitcoin narrative and speculation of a “strategic Bitcoin reserve” continue to drive enthusiasm. Holding above $6.64 remains crucial for maintaining bullish sentiment, while breaking $8.07 could open the path toward July’s peak near $11.92.

The discussion surrounding Bitcoin and gold as stores of value has been ongoing for years—and is gaining new relevance amid geopolitical tensions and high inflation.

Since Bitcoin recovered slightly today near $ 103,000, it has raised sentiment across the sector, which has lifted even the QNT price. Now, it has garnered support from key stakeholders, and bullish opinions have emerged, making the Quant price prediction 2025 very interesting. 

When writing, the renewed strength of BTC and rising interest in Quant’s tokenized finance infrastructure have helped QNT reclaim higher levels, setting the stage for a potentially explosive breakout.

QNT Rebounds as Bitcoin Recovers and Market Sentiment ImprovesQNT/USD remained within a compressed range from the beginning of this year, and even July’s rise was brief. From July to November, the price moved from the upper range to the lower range of this pattern, where the recent volatility around the Quant price emerged after the Federal Reserve’s 0.25% rate cut was overshadowed by uncertainty regarding future cuts. 

This uncertainty drove Bitcoin below $100,000 and pushed QNT down to $69 on November 4th. 

However, with Bitcoin recovering above $103,000, optimism returned across the market, allowing QNT price today to rebound to $88, marking a solid 28% recovery. It has slightly retraced to $84.30, with a market cap of $1.02 billion.

This sharp reversal aligns with a long-term ascending trendline visible on the Quant price chart, which has been respected since August 2024, November 2024, April 2025, and now November 2025. Each previous touch on this trendline led to a strong rally, making the current reaction another potentially significant turning point.

Symmetrical Triangle Compression Points to a 200% Breakout SetupThe technical structure surrounding Quant crypto continues to build interest. QNT price has spent months coiling within a symmetrical triangle pattern, creating a tightening range that often precedes major expansions. With the ascending trendline forming a strong foundation, the upper border of the triangle becomes the critical barrier to watch.

If the pattern resolves to the upside, historical behavior suggests a powerful continuation, potentially sending QNT toward $265 before the year ends, which would be a 200% rise from CMP. The longer the compression, the larger the probability of a substantial breakout.

QuantNet Narrative Boosts Confidence in Long-Term ValueBeyond technical signals, fundamental momentum is growing thanks to Quant’s expanding role in tokenized finance. On October 27, 2025, Quant emphasized that the world’s financial system is being rebuilt in real time, with money, assets, and payments rapidly becoming tokenized. 

Yet institutions operate in isolation with different ledgers, networks, and rules  resulting in fragmented liquidity and slow settlement processes.

Here comes the solution from Quant, which aims to solve this bottleneck through QuantNet, described as “the settlement fabric of the digital-asset era.” Rather than replacing existing systems, QuantNet connects them, enabling instant and compliant settlement between banks, tokenized assets, tokenized money, and legacy payment infrastructure.

🚀QuantNet: The Missing Layer in Tokenised Finance

The world’s financial system is being rebuilt in real time.

Money, assets, and payments are all becoming tokenised.

But something crucial is missing, a way to make them work together.

That’s why banks need QuantNet.

— Quant (@quantnetwork) October 27, 2025 This narrative has significantly fueled bullish sentiment, as institutions increasingly seek interoperability solutions that simplify tokenized finance. As adoption grows, the broader QNT price forecast 2025 becomes increasingly compelling.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

Haemonetics (HAE - Free Report) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.12 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +13.39%. A quarter ago, it was expected that this provider blood management systems for health care providers and blood collectors would post earnings of $1.01 per share when it actually produced earnings of $1.1, delivering a surprise of +8.91%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Haemonetics, which belongs to the Zacks Medical - Products industry, posted revenues of $327.32 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.22%. This compares to year-ago revenues of $345.51 million. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Haemonetics shares have lost about 35% since the beginning of the year versus the S&P 500's gain of 15.6%.

What's Next for Haemonetics?While Haemonetics has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Haemonetics was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.28 on $330.9 million in revenues for the coming quarter and $4.80 on $1.3 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Canopy Growth Corporation (CGC - Free Report) , has yet to report results for the quarter ended September 2025. The results are expected to be released on November 7.

This company is expected to post quarterly loss of $0.11 per share in its upcoming report, which represents a year-over-year change of +88.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Canopy Growth Corporation's revenues are expected to be $52.34 million, up 13.3% from the year-ago quarter.

Enovis (ENOV - Free Report) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.73 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +11.94%. A quarter ago, it was expected that this manufacturing and engineering company would post earnings of $0.74 per share when it actually produced earnings of $0.79, delivering a surprise of +6.76%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Enovis, which belongs to the Zacks Medical Info Systems industry, posted revenues of $548.91 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.41%. This compares to year-ago revenues of $505.22 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Enovis shares have lost about 28.2% since the beginning of the year versus the S&P 500's gain of 15.6%.

What's Next for Enovis?While Enovis has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Enovis was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.86 on $589.06 million in revenues for the coming quarter and $3.13 on $2.25 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Info Systems is currently in the top 26% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Nyxoah SA (NYXH - Free Report) , has yet to report results for the quarter ended September 2025. The results are expected to be released on November 13.

This company is expected to post quarterly loss of $0.61 per share in its upcoming report, which represents a year-over-year change of -10.9%. The consensus EPS estimate for the quarter has been revised 6.1% lower over the last 30 days to the current level.

Nyxoah SA's revenues are expected to be $1.95 million, up 40.5% from the year-ago quarter.

ACI Worldwide (ACIW - Free Report) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $0.97 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +10.10%. A quarter ago, it was expected that this maker of software for electronic payments would post earnings of $0.27 per share when it actually produced earnings of $0.35, delivering a surprise of +29.63%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

ACI Worldwide, which belongs to the Zacks Computer - Software industry, posted revenues of $482.36 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.16%. This compares to year-ago revenues of $451.75 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

ACI Worldwide shares have lost about 7.1% since the beginning of the year versus the S&P 500's gain of 15.6%.

What's Next for ACI Worldwide?While ACI Worldwide has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for ACI Worldwide was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.07 on $473.8 million in revenues for the coming quarter and $2.90 on $1.74 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computer - Software is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Salesforce.com (CRM - Free Report) , has yet to report results for the quarter ended October 2025.

This customer-management software developer is expected to post quarterly earnings of $2.85 per share in its upcoming report, which represents a year-over-year change of +18.3%. The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level.

Salesforce.com's revenues are expected to be $10.26 billion, up 8.7% from the year-ago quarter.

VSee explores collaboration with Philippine Tuberculosis Society and former VP Leni Robredo to expand digital health innovation for Naga City starting with maternal health and primary care SAN JOSE, CALIFORNIA / ACCESS Newswire / November 6, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leading provider of secure, AI-powered telehealth technology, joined the Philippine Tuberculosis Society and former Philippine Vice President Leni Robredo (currently mayor of Naga City) to discuss opportunities to enhance healthcare delivery in Naga City through digital health innovation. This initial discussion highlighted key healthcare challenges in Naga City, such as prenatal check-up rates-only 44% compared to the Department of Health's 99% target-and the city's efforts to expand access through healthcare caravans (mobile units) and health insurer PhilHealth's YAKAP project, which provides ₱1,700 (USD 29) per qualified patient to local government units delivering full primary care.